Stay updated on OPUS Clinical Trial: Natalizumab in Focal Epilepsy
Sign up to get notified when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.

Latest updates to the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page
- Check3 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing v3.3.3, with no changes to study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a comprehensive Locations section listing all study sites by state (Alabama, Arizona, California, District of Columbia, Florida, Hawaii, Illinois, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Texas, Washington) and updated the revision tag from v3.3.2 to v3.3.3.SummaryDifference2%

- Check53 days agoChange DetectedThe PubMed publications section text was updated to state that entries are auto-filled from PubMed and may not pertain to the study, and the revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page no longer shows the government funding/NIH operating status notice; other study details and links remain unchanged.SummaryDifference0.3%

- Check75 days agoChange DetectedThe two screenshots show the Study Details page with no substantive changes to content or structure; only minor UI or rendering differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check103 days agoChange DetectedMajor update: version bumped to v3.2.0 and a government funding/operating-status notice added; previous version v3.1.0 removed.SummaryDifference3%

Stay in the know with updates to OPUS Clinical Trial: Natalizumab in Focal Epilepsy
Enter your email address, and we'll notify you when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.